PRINCIPAL INVESTIGATOR (Rare and Undiagnosed Diseases)

Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases (LBI-RUD)
Job Location
1090 Vienna

Initial appointments will be made for up to seven years with tenure option, and the successful candidate will be offered a competitive salary and research budget. The institute will provide support and mentoring to apply for additional external research funding at the Austrian and European level. Two of the four Principal Investigators at LBI-RUD hold prestigious grants by the European Research Council. LBI-RUD researchers are well-connected in global networks and will support young investigators in their effort to build up own new research collaborations in the field of rare and undiagnosed diseases.

Job Description

Join Austria’s new research institute dedicated to the biological basis and molecular therapy of rare and undiagnosed diseases!

at the Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases (LBI-RUD) in Vienna, Austria

We are looking for an outstanding biomedical scientist who would be eager to start or consolidate their research group at an exciting new institute pursuing basic and translational research on rare diseases. Relevant disease areas include, but are not limited to, rare genetic diseases of hematopoiesis, the immune system and the nervous system. Systems biological approaches are equally appreciated as are focused mechanistic studies and translational research with direct clinical applications, or any combination of the above.

More than 7,000 rare diseases exist and affect around 5% of the population, constituting a major unmet medical need. Rare and undiagnosed diseases also offer unique opportunities to identify key genes and mechanisms underlying human physiology and diseases. Many rare diseases are caused by single-gene defects, thus enabling a clear mechanistic understanding of genotype-phenotype links relevant in humans and to develop concepts for personalized therapy. Rare and undiagnosed diseases are paradigmatic for the era of precision medicine, and LBI-RUD will broadly embrace their pioneering role for the future of medicine.

How to Apply

Please submit a detailed CV including publication list, information on research interests, single most important achievement, a short proposal of planned research, and contact details of 3 referees as a single PDF file to [email protected] (reference code #PI/LBIRUD16).Please also provide your timeline or earliest/latest starting date, respectively. Application deadline is 30th November 2016, or until the position is filled. 

About Our Organization

The Institute
LBI-RUD has established a coordinated research program on the genetic and epigenetic origin and the functional basis of rare diseases, with a special focus on inborn errors of the immune system and the nervous system. Previous scientific publications by the LBI-RUD key researchers have enabled the identification of novel genetic defects underlying primary immunodeficiency disorders (e.g. Boztug K et al Nature Genet 2014, Dobbs K et al New Engl J Med 2015, Salzer E et al Nat Immunol 2016), and monogenic neuronal diseases (Nagy V et al Cell Cycle 2015). The institute has first-hand access to the latest assays for high-throughput sequencing and single-cell profiling (Schmidl et al Nature Methods 2015, Bock et al Nat Biotechnol 2016). It also investigates the ethical and societal dimensions of rare diseases research. The institute is directed by Kaan Boztug, a leading immunologist and rare diseases researcher. It is situated in a beautiful and well-designed building with state-of-the-art laboratories and technology platforms, located next to one of the world’s largest university hospitals in the heart of Vienna. The institute holds close ties with its renowned partners, namely the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, the Medical University of Vienna, and the Children’s Cancer Research Institute of the St. Anna Children’s Hospital.
For more information please visit:
Institute homepage will be available shortly:

New study finds bias against female lecturers among student course evaluations, the Economist reports.

A research duo finds that science and technology graduate students who turn away from academic careers do so because of changes in their own interests.

Students whose classmates are interested in science are more likely to think about a career in science, technology, engineering, and mathematics, a new study says.

CNBC reports that the genetic counseling field is expected to grow as personalized medicine becomes more common.